CCND1 (Cyclin D1)

Compared with 18F-FDG, 68Ga-pentixafor PET/CT detected more lesions with significantly higher tracer uptake. This case suggests that, for patients with CLL/SLL, 68Ga-pentixafor PET/CT demonstrates significantly superior performance in evaluating the tumor burden and delineating the disease extent compared with 18F-FDG PET/CT.

Co-treatment with the AMPK inhibitor compound C abrogated these effects, confirming AMPK dependence. Collectively, SOP functions as a natural AMPK agonist that reprograms tumor metabolism and suppresses oncogenic signaling, highlighting its promise as a low-toxicity therapeutic candidate for liver cancer.

Expression of IRTA1 alone, or either IRTA1+ or MNDA+, was less frequent among MZL with plasma cell differentiation than among MZL with classical cell morphology (p=0.063 and 0.071, respectively), albeit not significantly. IRTA1 and MNDA are sensitive and specific markers for the differential diagnosis of MZL, and they may be helpful in distinguishing MZL from histologic mimics.

P1/2, N=8, Active, not recruiting, City of Hope Medical Center | Trial completion date: Feb 2026 --> Feb 2027 | Trial primary completion date: Feb 2026 --> Feb 2027

Specific inhibitors (SP600125, SB203580, NAC, Z-vad-fmk) were employed to validate the underlying mechanisms...Sch A selectively induces apoptosis in ESCC cells through ROS-JNK/p38-mediated pathways, mitochondrial dysfunction, and cell cycle arrest. These findings indicate that Sch A is a promising therapeutic candidate for treating ESCC.

We report a 63 year-old man with bone marrow involvement by mantle cell lymphoma displaying an immunohistochemical profile CD20+, CD5+, cyclin D1+, SOX11-, with distinctive features including blastoid morphology, diffuse TdT expression, and MYC gene rearrangement. This exceptional association of blastoid morphology, TdT expression, and MYC rearrangement in mantle cell lymphoma suggests a process of tumor dedifferentiation and broadens the clinico-biological spectrum of mantle cell lymphoma, raising significant diagnostic and prognostic challenges.

P2, N=50, Active, not recruiting, M.D. Anderson Cancer Center | Recruiting --> Active, not recruiting

P2, N=30, Recruiting, M.D. Anderson Cancer Center | Not yet recruiting --> Recruiting

Pharmacological inhibition of AMPK or p38 antagonized isoeugenol-suppressed cell growth, migration, invasion, and associated signaling events. In conclusion, these data suggest that isoeugenol may inhibit CRCC growth, migration, and invasion through activations of AMPK and p38 MAPK pathways and modulating pathways involved in cell cycle regulation and EMT.

These findings support EGFR, cyclin D1, and Bcl-2 as biomarkers which portend worse prognosis in HNSCC. Further work will be needed to understand whether measurement of these proteins can be useful in tailoring treatment strategies, and whether they can be used as targets for novel therapies.

In conclusion, miR-122 plays a dual role in liver regeneration. While its suppression enhances regeneration in healthy liver, loss of miR-122 under fibrotic conditions drives pathological repair, metabolic failure and lethality, highlighting its critical role in chronic liver disease.

Collectively, this study provides an approach to acclimatize A. orientalis that may be utilized for developing a cultivation method. Moreover, this green seaweed has a great potential to be used for nutraceutical and functional food applications.